Conjugate heat shock protein-binding peptides
OwnerJames E. Rothman, Mark Mayhew +5inventors
InventorsJames E. Rothman, Mark Mayhew, Mee H. Hoe, Alan Houghton, Ulrich Hartl, Ouathek Ouerfelli, Yoichi Moroi
Life of this patent
Estimating the term…
Loading patent…
OwnerJames E. Rothman, Mark Mayhew +5inventors
InventorsJames E. Rothman, Mark Mayhew, Mee H. Hoe, Alan Houghton, Ulrich Hartl, Ouathek Ouerfelli, Yoichi Moroi
Estimating the term…
The present related (i) to conjugate peptides engineered to noncovalently bind to heat shock proteins; (ii) to compositions comprising such conjugate peptides, optionally bound to heat shock protein; and (iii) to methods of using such compositions to induce an immune response in a subject in need of such treatment. It is based, at least in part, on the discovery of tethering molecules which may be used to non-covalently link antigenic peptides to heat shock proteins. The present invention also provides for methods of identifying additional tethers which may be comprised, together with antigenic sequences, in conjugate peptides.
A method of identifying a peptide which binds to a heat shock protein, comprising:
A method of identifying a peptide which binds to a heat shock protein, comprising:
A method of inducing an immune response in a subject in need of such treatment, comprising administering, to the subject, a composition comprising a conjugate peptide, wherein the conjugate peptide comprises (i) a portion which may be bound to a heat shock protein under physiologic conditions and (ii) a portion which is antigenic, wherein a heat shock protein is not concurrently administered with the conjugate peptide.
A conjugate peptide comprising an antigenic peptide and a benzaquinone ansamycin antibiotic.
Dependencies are inferred from the claim text.